A/Prof Shankar Siva

Associate Professor Shankar Siva is a Radiation Oncologist and current Cancer Council Victoria (CCV) Colebatch Fellow. He leads the Stereotactic Ablative Body Radiotherapy (SABR) program at the Peter Mac and is internationally recognised for his work in high technology radiotherapy delivery. He completed his PhD with the Molecular Radiation Biology (Martin) Laboratory focusing on translational investigations in precision high-dose lung radiotherapy. He published the first original research from Australia on the use of the SABR technique. 

Shankar leads multiple clinical trials in the treatment of lung and urological cancers at the Peter Mac, and is chair of five Trans Tasman Radiation Oncology Group (TROG) studies in the fields of oligometastases, lung, prostate and kidney cancers. His international commitments include positions on the Board of Directors of the Radiosurgery Society (RSS), the International Association for the Study of Lung Cancer (IASLC) Advanced Radiation Technology (ART) committee, American Society of Radiation Oncology (ASTRO) Science Council, and Course Director of European Society for Radiotherapy (ESTRO) SBRT Asia. At an Australasian level, he is Co-Chair of the TROG Genitourinary Group, a member of Management Advisory Committee (MAC) of the Australasian Lung Cancer Trials Group (ALTG), amongst other leadership roles. He has research interests in high-tech radiotherapy delivery, SABR and radiation immunology.